quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:07:57·890d
NEWSRelease
AgileThought Inc. logo
reAlpha Tech Corp. logo
Arcturus Therapeutics Holdings Inc. logo
+17

Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket

AGIL· AgileThought Inc.AIRE· reAlpha Tech Corp.ARCT· Arcturus Therapeutics Holdings Inc.CRMD· CorMedix Inc.EGOX· Next.e.GO N.V.ELIQ· Electriq Power Holdings Inc.
Consumer DiscretionaryFinanceHealth Care
Original source

Companies

  • AGIL
    AgileThought Inc.
    Consumer Discretionary
  • AIRE
    reAlpha Tech Corp.
    Finance
  • ARCT
    Arcturus Therapeutics Holdings Inc.
    Health Care
  • CRMD
    CorMedix Inc.
    Health Care
  • EGOX
    Next.e.GO N.V.
  • ELIQ
    Electriq Power Holdings Inc.
    Miscellaneous
  • GDEV
    GDEV Inc.
    Technology
  • HRTX
    Heron Therapeutics Inc.
    Health Care
  • HSCS
    HeartSciences Inc.
    Health Care
  • INTZ
    Intrusion Inc.
    Telecommunications
  • MGOL
    MGO Global Inc.
    Consumer Discretionary
  • MNTS
    Momentus Inc.
    Industrials
  • MRAI
    Marpai Inc.
    Health Care
  • MYTE
    MYT Netherlands Parent B.V.
    Consumer Discretionary
  • PIK
    Kidpik Corp.
    Consumer Discretionary
  • PRSO
    Peraso Inc.
    Technology
  • SLDB
    Solid Biosciences Inc.
    Health Care
  • TCJH
    Top KingWin Ltd
    Consumer Discretionary
  • TIVC
    Tivic Health Systems Inc.
    Health Care
  • VREX
    Varex Imaging Corporation
    Technology

Recent analyst ratings

  • Mar 20SLDBUpdateGuggenheim$26.00
  • Mar 18ARCTUpdateB. Riley Securities$22.00
  • Jan 23ARCTUpdateRoth Capital$20.00
  • Dec 4SLDBUpdateNeedham$16.00
  • Nov 26AIREUpdateH.C. Wainwright$2.00
  • Oct 24ARCTUpdateH.C. Wainwright$12.00

Related

  • SEC13h
    Tivic Health Systems Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • SEC13h
    SEC Form DEFA14A filed by Solid Biosciences Inc.
  • PR13h
    Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model
  • SEC13h
    SEC Form DEF 14A filed by Solid Biosciences Inc.
  • SEC1d
    SEC Form SCHEDULE 13G filed by Momentus Inc.
  • PR1d
    Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call
  • SEC2d
    SEC Form S-3 filed by Momentus Inc.
  • INSIDER2d
    SEC Form 4 filed by Tan Kevin
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022